We have shown that in the group of HER2(+) breast cancer patients, there is a statistically significant increase in the amino acids Leu + Ile, Orn, Pro, Tyr Asp, Gly, Phe, and His compared to the HER2(−) group and the controls. The gene discussed is ERBB2; the disease is breast carcinoma.